Concepedia

Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy

Y. Ikari, Kentaro Ogata, Yuta Nakashima, Eiichi Sato, Michio Masaki, Hiroo Katsuya, Toshitaka Goto, Toshihiro Tanaka, Kenji Ishitsuka, Yasushi Takamatsu,

Supportive Care in Cancer · 2014 · 10 citations · 10 references

DOI

Concepts

References

10

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Mitsue Saito, Kenjiro Aogi, Ikuo Sekine et al. · The Lancet Oncology · 2009 · 434 citations

, , +14

Lancet Oncol 10

Jack Cuzick, Ivana Šestak, Sarah E. Pinder et al. · 2013 · 431 citations

Pharmacokinetic and Safety Evaluation of Palonosetron, a 5‐Hydroxytryptamine‐3 Receptor Antagonist, in U.S. and Japanese Healthy Subjects

Randall Stoltz, Jong‐Chol Cyong, Ajit Shah et al. · The Journal of Clinical Pharmacology · 2004 · 159 citations

, , +13

Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer

Lawrence H. Einhorn, Mary J. Brames, Robert Dreicer et al. · Supportive Care in Cancer · 2007 · 94 citations

, , +16

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Makoto Maemondo, N Masuda, Ikuo Sekine et al. · Annals of Oncology · 2009 · 56 citations · Full text

, , +12